In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.

Stivala, Simona; Gobbato, Sara; Infanti, Laura; Reiner, Martin F; Bonetti, Nicole; Meyer, Sara C.; Camici, Giovanni G; Lüscher, Thomas F; Buser, Andreas; Beer, Juerg H (2017). In response to the comment by Hechler et al.: Amotosalen/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance. Haematologica - the hematology journal, 102(12), e504-e505. Ferrata-Storti Foundation 10.3324/haematol.2017.181818

[img] Text
8303-Article_Text-57017-1-10-20200724.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (227kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Meyer, Sara Christina

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0390-6078

Publisher:

Ferrata-Storti Foundation

Language:

English

Submitter:

Julia Elisa Garcia

Date Deposited:

27 Dec 2023 08:29

Last Modified:

27 Dec 2023 08:38

Publisher DOI:

10.3324/haematol.2017.181818

PubMed ID:

29192132

BORIS DOI:

10.48350/190299

URI:

https://boris.unibe.ch/id/eprint/190299

Actions (login required)

Edit item Edit item
Provide Feedback